カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の女性用避妊薬市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Female Contraception Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19319）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19319
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：93
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の女性用避妊薬市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

女性用避妊薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の女性用避妊薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

女性用避妊薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・AG-890、アンフォラ、BAY-1007626、ドロスピレノン、その他

用途別セグメントは次のように区分されます。
・診療所、病院、在宅医療

世界の女性用避妊薬市場の主要な市場プレーヤーは以下のとおりです。
・Addex Therapeutics Ltd、Agile Therapeutics Inc、Bayer AG、Evofem Inc、Hervana Ltd、Mithra Pharmaceuticals SA、Orbis Biosciences Inc、Teva Pharmaceutical Industries Ltd、Viramal Ltd

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、女性用避妊薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な女性用避妊薬メーカーの企業概要、2019年～2022年までの女性用避妊薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な女性用避妊薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別女性用避妊薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの女性用避妊薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での女性用避妊薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および女性用避妊薬の産業チェーンを掲載しています。
・第13、14、15章では、女性用避妊薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 女性用避妊薬の概要
- 種類別分析（2017年vs2021年vs2028年）：AG-890、アンフォラ、BAY-1007626、ドロスピレノン、その他
- 用途別分析（2017年vs2021年vs2028年）：診療所、病院、在宅医療
- 世界の女性用避妊薬市場規模・予測
- 世界の女性用避妊薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Addex Therapeutics Ltd、Agile Therapeutics Inc、Bayer AG、Evofem Inc、Hervana Ltd、Mithra Pharmaceuticals SA、Orbis Biosciences Inc、Teva Pharmaceutical Industries Ltd、Viramal Ltd
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：AG-890、アンフォラ、BAY-1007626、ドロスピレノン、その他
・用途別分析2017年-2028年：診療所、病院、在宅医療
・女性用避妊薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・女性用避妊薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・女性用避妊薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・女性用避妊薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・女性用避妊薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Female Contraception Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Female Contraception Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Clinic accounting for % of the Female Contraception Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While AG-890 segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Female Contraception Drug include Addex Therapeutics Ltd, Agile Therapeutics Inc, Bayer AG, Evofem Inc, and Hervana Ltd, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Female Contraception Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
AG-890
Amphora
BAY-1007626
Drospirenone
Others
Market segment by Application can be divided into
Clinic
Hospital
Homecare
The key market players for global Female Contraception Drug market are listed below:
Addex Therapeutics Ltd
Agile Therapeutics Inc
Bayer AG
Evofem Inc
Hervana Ltd
Mithra Pharmaceuticals SA
Orbis Biosciences Inc
Teva Pharmaceutical Industries Ltd
Viramal Ltd
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Female Contraception Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Female Contraception Drug, with price, sales, revenue and global market share of Female Contraception Drug from 2019 to 2022.
Chapter 3, the Female Contraception Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Female Contraception Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Female Contraception Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Female Contraception Drug.
Chapter 13, 14, and 15, to describe Female Contraception Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Female Contraception Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Female Contraception Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 AG-890
1.2.3 Amphora
1.2.4 BAY-1007626
1.2.5 Drospirenone
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Female Contraception Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Homecare
1.4 Global Female Contraception Drug Market Size & Forecast
1.4.1 Global Female Contraception Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Female Contraception Drug Sales in Volume (2017-2028)
1.4.3 Global Female Contraception Drug Price (2017-2028)
1.5 Global Female Contraception Drug Production Capacity Analysis
1.5.1 Global Female Contraception Drug Total Production Capacity (2017-2028)
1.5.2 Global Female Contraception Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Female Contraception Drug Market Drivers
1.6.2 Female Contraception Drug Market Restraints
1.6.3 Female Contraception Drug Trends Analysis
2 Manufacturers Profiles
2.1 Addex Therapeutics Ltd
2.1.1 Addex Therapeutics Ltd Details
2.1.2 Addex Therapeutics Ltd Major Business
2.1.3 Addex Therapeutics Ltd Female Contraception Drug Product and Services
2.1.4 Addex Therapeutics Ltd Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Agile Therapeutics Inc
2.2.1 Agile Therapeutics Inc Details
2.2.2 Agile Therapeutics Inc Major Business
2.2.3 Agile Therapeutics Inc Female Contraception Drug Product and Services
2.2.4 Agile Therapeutics Inc Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Bayer AG
2.3.1 Bayer AG Details
2.3.2 Bayer AG Major Business
2.3.3 Bayer AG Female Contraception Drug Product and Services
2.3.4 Bayer AG Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Evofem Inc
2.4.1 Evofem Inc Details
2.4.2 Evofem Inc Major Business
2.4.3 Evofem Inc Female Contraception Drug Product and Services
2.4.4 Evofem Inc Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Hervana Ltd
2.5.1 Hervana Ltd Details
2.5.2 Hervana Ltd Major Business
2.5.3 Hervana Ltd Female Contraception Drug Product and Services
2.5.4 Hervana Ltd Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Mithra Pharmaceuticals SA
2.6.1 Mithra Pharmaceuticals SA Details
2.6.2 Mithra Pharmaceuticals SA Major Business
2.6.3 Mithra Pharmaceuticals SA Female Contraception Drug Product and Services
2.6.4 Mithra Pharmaceuticals SA Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Orbis Biosciences Inc
2.7.1 Orbis Biosciences Inc Details
2.7.2 Orbis Biosciences Inc Major Business
2.7.3 Orbis Biosciences Inc Female Contraception Drug Product and Services
2.7.4 Orbis Biosciences Inc Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Teva Pharmaceutical Industries Ltd
2.8.1 Teva Pharmaceutical Industries Ltd Details
2.8.2 Teva Pharmaceutical Industries Ltd Major Business
2.8.3 Teva Pharmaceutical Industries Ltd Female Contraception Drug Product and Services
2.8.4 Teva Pharmaceutical Industries Ltd Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Viramal Ltd
2.9.1 Viramal Ltd Details
2.9.2 Viramal Ltd Major Business
2.9.3 Viramal Ltd Female Contraception Drug Product and Services
2.9.4 Viramal Ltd Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Female Contraception Drug Breakdown Data by Manufacturer
3.1 Global Female Contraception Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Female Contraception Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Female Contraception Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Female Contraception Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Female Contraception Drug Manufacturer Market Share in 2021
3.5 Global Female Contraception Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Female Contraception Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Female Contraception Drug Market Size by Region
4.1.1 Global Female Contraception Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Female Contraception Drug Revenue by Region (2017-2028)
4.2 North America Female Contraception Drug Revenue (2017-2028)
4.3 Europe Female Contraception Drug Revenue (2017-2028)
4.4 Asia-Pacific Female Contraception Drug Revenue (2017-2028)
4.5 South America Female Contraception Drug Revenue (2017-2028)
4.6 Middle East and Africa Female Contraception Drug Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Female Contraception Drug Sales in Volume by Type (2017-2028)
5.2 Global Female Contraception Drug Revenue by Type (2017-2028)
5.3 Global Female Contraception Drug Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Female Contraception Drug Sales in Volume by Application (2017-2028)
6.2 Global Female Contraception Drug Revenue by Application (2017-2028)
6.3 Global Female Contraception Drug Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Female Contraception Drug Sales by Type (2017-2028)
7.2 North America Female Contraception Drug Sales by Application (2017-2028)
7.3 North America Female Contraception Drug Market Size by Country
7.3.1 North America Female Contraception Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Female Contraception Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Female Contraception Drug Sales by Type (2017-2028)
8.2 Europe Female Contraception Drug Sales by Application (2017-2028)
8.3 Europe Female Contraception Drug Market Size by Country
8.3.1 Europe Female Contraception Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Female Contraception Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Female Contraception Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Female Contraception Drug Sales by Application (2017-2028)
9.3 Asia-Pacific Female Contraception Drug Market Size by Region
9.3.1 Asia-Pacific Female Contraception Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Female Contraception Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Female Contraception Drug Sales by Type (2017-2028)
10.2 South America Female Contraception Drug Sales by Application (2017-2028)
10.3 South America Female Contraception Drug Market Size by Country
10.3.1 South America Female Contraception Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Female Contraception Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Female Contraception Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Female Contraception Drug Sales by Application (2017-2028)
11.3 Middle East & Africa Female Contraception Drug Market Size by Country
11.3.1 Middle East & Africa Female Contraception Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Female Contraception Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Female Contraception Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Female Contraception Drug
12.3 Female Contraception Drug Production Process
12.4 Female Contraception Drug Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Female Contraception Drug Typical Distributors
13.3 Female Contraception Drug Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Female Contraception Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Female Contraception Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Addex Therapeutics Ltd Basic Information, Manufacturing Base and Competitors
Table 4. Addex Therapeutics Ltd Major Business
Table 5. Addex Therapeutics Ltd Female Contraception Drug Product and Services
Table 6. Addex Therapeutics Ltd Female Contraception Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Agile Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 8. Agile Therapeutics Inc Major Business
Table 9. Agile Therapeutics Inc Female Contraception Drug Product and Services
Table 10. Agile Therapeutics Inc Female Contraception Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 12. Bayer AG Major Business
Table 13. Bayer AG Female Contraception Drug Product and Services
Table 14. Bayer AG Female Contraception Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Evofem Inc Basic Information, Manufacturing Base and Competitors
Table 16. Evofem Inc Major Business
Table 17. Evofem Inc Female Contraception Drug Product and Services
Table 18. Evofem Inc Female Contraception Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Hervana Ltd Basic Information, Manufacturing Base and Competitors
Table 20. Hervana Ltd Major Business
Table 21. Hervana Ltd Female Contraception Drug Product and Services
Table 22. Hervana Ltd Female Contraception Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Mithra Pharmaceuticals SA Basic Information, Manufacturing Base and Competitors
Table 24. Mithra Pharmaceuticals SA Major Business
Table 25. Mithra Pharmaceuticals SA Female Contraception Drug Product and Services
Table 26. Mithra Pharmaceuticals SA Female Contraception Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Orbis Biosciences Inc Basic Information, Manufacturing Base and Competitors
Table 28. Orbis Biosciences Inc Major Business
Table 29. Orbis Biosciences Inc Female Contraception Drug Product and Services
Table 30. Orbis Biosciences Inc Female Contraception Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 32. Teva Pharmaceutical Industries Ltd Major Business
Table 33. Teva Pharmaceutical Industries Ltd Female Contraception Drug Product and Services
Table 34. Teva Pharmaceutical Industries Ltd Female Contraception Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Viramal Ltd Basic Information, Manufacturing Base and Competitors
Table 36. Viramal Ltd Major Business
Table 37. Viramal Ltd Female Contraception Drug Product and Services
Table 38. Viramal Ltd Female Contraception Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Female Contraception Drug Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Pcs)
Table 40. Global Female Contraception Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Female Contraception Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Female Contraception Drug Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 43. Head Office and Female Contraception Drug Production Site of Key Manufacturer
Table 44. Female Contraception Drug New Entrant and Capacity Expansion Plans
Table 45. Female Contraception Drug Mergers & Acquisitions in the Past Five Years
Table 46. Global Female Contraception Drug Sales by Region (2017-2022) & (K Pcs)
Table 47. Global Female Contraception Drug Sales by Region (2023-2028) & (K Pcs)
Table 48. Global Female Contraception Drug Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Female Contraception Drug Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Female Contraception Drug Sales by Type (2017-2022) & (K Pcs)
Table 51. Global Female Contraception Drug Sales by Type (2023-2028) & (K Pcs)
Table 52. Global Female Contraception Drug Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Female Contraception Drug Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Female Contraception Drug Price by Type (2017-2022) & (USD/Pcs)
Table 55. Global Female Contraception Drug Price by Type (2023-2028) & (USD/Pcs)
Table 56. Global Female Contraception Drug Sales by Application (2017-2022) & (K Pcs)
Table 57. Global Female Contraception Drug Sales by Application (2023-2028) & (K Pcs)
Table 58. Global Female Contraception Drug Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Female Contraception Drug Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Female Contraception Drug Price by Application (2017-2022) & (USD/Pcs)
Table 61. Global Female Contraception Drug Price by Application (2023-2028) & (USD/Pcs)
Table 62. North America Female Contraception Drug Sales by Country (2017-2022) & (K Pcs)
Table 63. North America Female Contraception Drug Sales by Country (2023-2028) & (K Pcs)
Table 64. North America Female Contraception Drug Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Female Contraception Drug Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Female Contraception Drug Sales by Type (2017-2022) & (K Pcs)
Table 67. North America Female Contraception Drug Sales by Type (2023-2028) & (K Pcs)
Table 68. North America Female Contraception Drug Sales by Application (2017-2022) & (K Pcs)
Table 69. North America Female Contraception Drug Sales by Application (2023-2028) & (K Pcs)
Table 70. Europe Female Contraception Drug Sales by Country (2017-2022) & (K Pcs)
Table 71. Europe Female Contraception Drug Sales by Country (2023-2028) & (K Pcs)
Table 72. Europe Female Contraception Drug Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Female Contraception Drug Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Female Contraception Drug Sales by Type (2017-2022) & (K Pcs)
Table 75. Europe Female Contraception Drug Sales by Type (2023-2028) & (K Pcs)
Table 76. Europe Female Contraception Drug Sales by Application (2017-2022) & (K Pcs)
Table 77. Europe Female Contraception Drug Sales by Application (2023-2028) & (K Pcs)
Table 78. Asia-Pacific Female Contraception Drug Sales by Region (2017-2022) & (K Pcs)
Table 79. Asia-Pacific Female Contraception Drug Sales by Region (2023-2028) & (K Pcs)
Table 80. Asia-Pacific Female Contraception Drug Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Female Contraception Drug Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Female Contraception Drug Sales by Type (2017-2022) & (K Pcs)
Table 83. Asia-Pacific Female Contraception Drug Sales by Type (2023-2028) & (K Pcs)
Table 84. Asia-Pacific Female Contraception Drug Sales by Application (2017-2022) & (K Pcs)
Table 85. Asia-Pacific Female Contraception Drug Sales by Application (2023-2028) & (K Pcs)
Table 86. South America Female Contraception Drug Sales by Country (2017-2022) & (K Pcs)
Table 87. South America Female Contraception Drug Sales by Country (2023-2028) & (K Pcs)
Table 88. South America Female Contraception Drug Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Female Contraception Drug Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Female Contraception Drug Sales by Type (2017-2022) & (K Pcs)
Table 91. South America Female Contraception Drug Sales by Type (2023-2028) & (K Pcs)
Table 92. South America Female Contraception Drug Sales by Application (2017-2022) & (K Pcs)
Table 93. South America Female Contraception Drug Sales by Application (2023-2028) & (K Pcs)
Table 94. Middle East & Africa Female Contraception Drug Sales by Region (2017-2022) & (K Pcs)
Table 95. Middle East & Africa Female Contraception Drug Sales by Region (2023-2028) & (K Pcs)
Table 96. Middle East & Africa Female Contraception Drug Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Female Contraception Drug Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Female Contraception Drug Sales by Type (2017-2022) & (K Pcs)
Table 99. Middle East & Africa Female Contraception Drug Sales by Type (2023-2028) & (K Pcs)
Table 100. Middle East & Africa Female Contraception Drug Sales by Application (2017-2022) & (K Pcs)
Table 101. Middle East & Africa Female Contraception Drug Sales by Application (2023-2028) & (K Pcs)
Table 102. Female Contraception Drug Raw Material
Table 103. Key Manufacturers of Female Contraception Drug Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Female Contraception Drug Typical Distributors
Table 107. Female Contraception Drug Typical Customers
List of Figures
Figure 1. Female Contraception Drug Picture
Figure 2. Global Female Contraception Drug Revenue Market Share by Type in 2021
Figure 3. AG-890
Figure 4. Amphora
Figure 5. BAY-1007626
Figure 6. Drospirenone
Figure 7. Others
Figure 8. Global Female Contraception Drug Revenue Market Share by Application in 2021
Figure 9. Clinic
Figure 10. Hospital
Figure 11. Homecare
Figure 12. Global Female Contraception Drug Revenue, (USD Million) & (K Pcs): 2017 & 2021 & 2028
Figure 13. Global Female Contraception Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Female Contraception Drug Sales (2017-2028) & (K Pcs)
Figure 15. Global Female Contraception Drug Price (2017-2028) & (USD/Pcs)
Figure 16. Global Female Contraception Drug Production Capacity (2017-2028) & (K Pcs)
Figure 17. Global Female Contraception Drug Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Female Contraception Drug Market Drivers
Figure 19. Female Contraception Drug Market Restraints
Figure 20. Female Contraception Drug Market Trends
Figure 21. Global Female Contraception Drug Sales Market Share by Manufacturer in 2021
Figure 22. Global Female Contraception Drug Revenue Market Share by Manufacturer in 2021
Figure 23. Female Contraception Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Female Contraception Drug Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Female Contraception Drug Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Female Contraception Drug Sales Market Share by Region (2017-2028)
Figure 27. Global Female Contraception Drug Revenue Market Share by Region (2017-2028)
Figure 28. North America Female Contraception Drug Revenue (2017-2028) & (USD Million)
Figure 29. Europe Female Contraception Drug Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Female Contraception Drug Revenue (2017-2028) & (USD Million)
Figure 31. South America Female Contraception Drug Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Female Contraception Drug Revenue (2017-2028) & (USD Million)
Figure 33. Global Female Contraception Drug Sales Market Share by Type (2017-2028)
Figure 34. Global Female Contraception Drug Revenue Market Share by Type (2017-2028)
Figure 35. Global Female Contraception Drug Price by Type (2017-2028) & (USD/Pcs)
Figure 36. Global Female Contraception Drug Sales Market Share by Application (2017-2028)
Figure 37. Global Female Contraception Drug Revenue Market Share by Application (2017-2028)
Figure 38. Global Female Contraception Drug Price by Application (2017-2028) & (USD/Pcs)
Figure 39. North America Female Contraception Drug Sales Market Share by Type (2017-2028)
Figure 40. North America Female Contraception Drug Sales Market Share by Application (2017-2028)
Figure 41. North America Female Contraception Drug Sales Market Share by Country (2017-2028)
Figure 42. North America Female Contraception Drug Revenue Market Share by Country (2017-2028)
Figure 43. United States Female Contraception Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Female Contraception Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Female Contraception Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Female Contraception Drug Sales Market Share by Type (2017-2028)
Figure 47. Europe Female Contraception Drug Sales Market Share by Application (2017-2028)
Figure 48. Europe Female Contraception Drug Sales Market Share by Country (2017-2028)
Figure 49. Europe Female Contraception Drug Revenue Market Share by Country (2017-2028)
Figure 50. Germany Female Contraception Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Female Contraception Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Female Contraception Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Female Contraception Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Female Contraception Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Female Contraception Drug Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Female Contraception Drug Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Female Contraception Drug Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Female Contraception Drug Revenue Market Share by Region (2017-2028)
Figure 59. China Female Contraception Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Female Contraception Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Female Contraception Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Female Contraception Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Female Contraception Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Female Contraception Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Female Contraception Drug Sales Market Share by Type (2017-2028)
Figure 66. South America Female Contraception Drug Sales Market Share by Application (2017-2028)
Figure 67. South America Female Contraception Drug Sales Market Share by Country (2017-2028)
Figure 68. South America Female Contraception Drug Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Female Contraception Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Female Contraception Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Female Contraception Drug Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Female Contraception Drug Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Female Contraception Drug Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Female Contraception Drug Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Female Contraception Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Female Contraception Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Female Contraception Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Female Contraception Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Female Contraception Drug in 2021
Figure 80. Manufacturing Process Analysis of Female Contraception Drug
Figure 81. Female Contraception Drug Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 長時間作用型可逆的避妊薬（LARC）のグローバル市場展望 2023年-2029年：子宮内避妊器具（IUC）、皮下インプラント
  • 世界の女性用乳房インプラント市場2022年：市場規模予測（～2028年）
  • 世界の空気圧手動めねじカプラー市場2022年：市場規模予測（～2028年）
  • 世界のゴセレリン薬物市場2022年：市場規模予測（～2028年）
  • 世界の神経線維腫症治療薬市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19319 )"世界の女性用避妊薬市場2022年：市場規模予測（～2028年）" (英文：Global Female Contraception Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。